Xue-Ru Wu
Molecular Biology · 2005
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 8 citations into it
- Oncology — 6 citations into it
Whom Xue-Ru Wu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Xue-Ru Wu's perspective
Ordered by how strongly the researchers Xue-Ru Wu trusts endorse each paper. Same corpus, a different order for every researcher.
- The INK4a/ARF network in tumour suppression (Nature reviews. Molecular cell biology)
- Epigenetics in human disease and prospects for epigenetic therapy (Nature)
- The discovery of receptor tyrosine kinases: targets for cancer therapy (Nature Reviews. Cancer)
- Estimating the world cancer burden: Globocan 2000 (International Journal of Cancer)
- Fibroblast growth factors. (Current Biology)
- Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets (International Journal of Cancer)
- Targeting RAS signalling pathways in cancer therapy (Nature Reviews. Cancer)
- Modelling the molecular circuitry of cancer (Nature Reviews. Cancer)
- Prospective identification of tumorigenic breast cancer cells (Proceedings of the National Academy of Sciences of the United States of America)
- Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice (Nature Genetics)
Their papers
- Urothelial tumorigenesis: a tale of divergent pathways (2005) — 708 citations